Skip to content

The study of half effective dose of propofol for painless gastroscopy in elderly patients with frailty

The study of half effective dose of propofol for painless gastroscopy in elderly patients with frailty

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064109
Enrollment
Unknown
Registered
2022-09-26
Start date
2022-09-20
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frailty

Interventions

Cohort 2:No

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 65 years; 2. ASA class I-III; 3. Scheduled to undergo a painless gastroscopy.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications for routine endoscopic procedures or who refuse anesthesia; 2. Patients who require endotracheal intubation; 3. Patients with uncontrolled and potentially life-threatening circulatory or respiratory diseases,severe liver dysfunction (Child-Pugh C), severe renal dysfunction, acute upper gastrointestinal hemorrhage with shock, severe anemia, or gastrointestinal obstruction with gastric content retention; 4. Patients without escort or guardian; 5. Patients who allergic to narcotic drugs, opioids or other anesthesia-related drugs; 6. Patients with difficult airway; 7. Patients with severe neurological or psychiatric disorders; 8. Substance abuser; 9. Patients with morbid obesity; 10. Patients with other high risk of anesthesia.

Design outcomes

Primary

MeasureTime frame
FRAIL scale Score;Dosage of propofol;Ramsay sedation scale Score;Response to the endoscopy;

Secondary

MeasureTime frame
Complications;Vital signs;

Countries

China

Contacts

Public ContactFushan Xue

Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University

xuefushan@aliyun.com+86 13911177655

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026